• Embed Doc
  • Copy Link
  • Readcast
  • Collections
Flexible Surgery Therapies FST,

A
Novel
Modality

to Surgical
Repair
Summary
Proprietary
,StrictlyCo
nfidential

Safe, Permanent Fixation For
Endoluminal AAA Repair
With Non-Stented Endograft

First Animal Results
Short Time To Market
Addressing Large Markets
Strong Senior Management
Graft Fastener Assembly With
First Non-stented Endograft
Incubator Financing
New Technology Concept
$1 Million in Development Services

Initial animal data (porcine model)
show durability, safety and
efficacy in proximal fixation

Growing market potential of 1.7
million patients ~$500m Market in
the U.S. alone

Relevant Experience \u2013 Clinical
Leader, Entrepreneur, Engineers
1 year to FDA approval,
2 years to market
of 00

Commenting has been disabled.